Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ethyl icosapentate in severe hypertriglyceridemia (China, Phase 3)
CTR20191474Phase 3Completed
- Sponsor
- Mochida Pharmaceutical Co., Ltd.
- Start
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Epadel in hypertriglyceridemia, sponsored by Mochida Pharmaceutical Co., Ltd.. Started Oct 2019; status: completed.
02
Drugs
Epadel
03
Conditions
hypertriglyceridemia
Beyond the preview
Go deeper on CTR20191474.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20191474.